THE EFFECT OF A DUAL RECEPTOR GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON AGONIST, COTADUTIDE, ON SERUM METABOLOME IN BIOPSY PROVEN NON-CIRRHOTIC NASH WITH FIBROSIS

被引：0
|
作者：
Daniels, Samuel J. [1 ]
Robertson, Darren [1 ]
Challis, Benjamin [2 ]
Sanyal, Arun J. [3 ]
Shankar, Sudha S. [4 ]
机构：
[1] Astrazeneca, Early Clin Dev Cardiovasc Renal & Metab, Biopharmaceut R&D, Cambridge, England
[2] Astrazeneca, Translat Sci & Expt Med, Res & Early Dev, Cardiovasc Renal & Metab,Biopharmaceut R&D, Cambridge, England
[3] Stravitz Sanyal Inst Liver Dis & Metab Hlth, VCU Sch Med, Dept Internal Med, Richmond, VA USA
[4] Astrazeneca, Early & Late Clin Dev, Cardiovasc Renal & Metab, Biopharmaceut R& D, Cambridge, England
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
101
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [31] Glucagon-Like Peptide-1 Receptor Agonist Treatment in Liver Cirrhosis - Reply
    Yen, Fu-Shun
    Hwu, Chii-Min
    Hsu, Chih-Cheng
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (04) : 902 - 903
  • [32] Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist
    Baron, Helen L.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S17 - S28
  • [33] Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats
    Fang, Jidong
    Miller, Patti
    Grigson, Patricia S.
    BRAIN RESEARCH BULLETIN, 2023, 192 : 142 - 155
  • [34] Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?
    Holst, Jens Juul
    LANCET, 2019, 394 (10192): : 4 - 6
  • [35] The Glucagon-Like Peptide-1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis
    Dichtel, Laura E.
    HEPATOLOGY, 2021, 74 (04) : 2290 - 2292
  • [36] Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes
    Claus, Thomas H.
    Pan, Clark Q.
    Buxton, Joanne M.
    Yang, Ling
    Reynolds, Jennifer C.
    Barucci, Nicole
    Burns, Michael
    Ortiz, Astrid A.
    Roczniak, Steve
    Livingston, James N.
    Clairmont, Kevin B.
    Whelan, James P.
    JOURNAL OF ENDOCRINOLOGY, 2007, 192 (02) : 371 - 380
  • [37] Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss
    Durell, Natalie
    Franks, Rachel
    Coon, Scott
    Cowart, Kevin
    Carris, Nicholas W.
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (05) : 283 - 288
  • [38] Equine glucagon-like peptide-1 receptor physiology
    Kheder, Murad H.
    Bailey, Simon R.
    Dudley, Kevin J.
    Sillence, Martin N.
    de Laat, Melody A.
    PEERJ, 2018, 6
  • [39] Amino acids are sensitive glucagon receptor-specific biomarkers for glucagon-like peptide-1 receptor/glucagon receptor dual agonists
    Li, Wenyu
    Kirchner, Thomas
    Ho, George
    Bonilla, Fany
    D'Aquino, Katharine
    Littrell, James
    Zhang, Rui
    Jian, Wenying
    Qiu, Xi
    Zheng, Songmao
    Gao, Bin
    Wong, Peggy
    Leonard, James N.
    Camacho, Raul C.
    DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2437 - 2450
  • [40] Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis
    Felson, David T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (17): : 1643 - 1644
12345